JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Philippe Noirhomme
Gébrine El Khoury
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montant, P.
Right arrow Articles by Vanoverschelde, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Montant, P.
Right arrow Articles by Vanoverschelde, J.-L.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2009;138:1339-1348
© 2009 The American Association for Thoracic Surgery


Acquired Cardiovascular Disease

Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach

Patrick Montant, MDa,*, Fabien Chenot, MDa,*, Annie Robert, PhDb, David Vancraeynest, MDa, Agnès Pasquet, MD, PhDa, Bernard Gerber, MD, PhDa, Philippe Noirhomme, MDa, Gébrine El Khoury, MDa, Jean-Louis Vanoverschelde, MD, PhDa,*

a Division of Cardiology, Cliniques Universitaires, St-Luc, Université Catholique de Louvain, Brussels, Belgium
b Epidemiology and Biostatistics Unit, Université Catholique de Louvain, Brussels, Belgium

Received for publication May 19, 2008; revisions received February 27, 2009; accepted for publication March 29, 2009.

* Address for reprints: Jean-Louis Vanoverschelde, MD, PhD, Division of Cardiology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10-2881, B-1200 Brussels, Belgium. (Email: vanoverschelde{at}card.ucl.ac.be).

Aims: The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair.

Methods: One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years.

Results: Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a "conservative approach" group (n = 67) and an "early surgery" group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively.

Conclusion: Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.



Abbreviations and Acronyms AF = atrial fibrillation; CABG = coronary artery bypass graft surgery; LV = left ventricular; MR = mitral regurgitation





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ghoreishi, C. F. Evans, C. R. DeFilippi, G. Hobbs, C. A. Young, B. P. Griffith, and J. S. Gammie
Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing of surgery
J. Thorac. Cardiovasc. Surg., December 1, 2011; 142(6): 1439 - 1452.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. H. Adams, J. Chikwe, F. Filsoufi, and A. C. Anyanwu
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., March 29, 2011; 57(13): 1425 - 1444.
[Full Text] [PDF]


Home page
HeartHome page
Z. Samad, P. Kaul, L. K. Shaw, D. D. Glower, E. J. Velazquez, P. S. Douglas, and J. G. Jollis
Impact of early surgery on survival of patients with severe mitral regurgitation
Heart, February 1, 2011; 97(3): 221 - 224.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F. Grigioni and A. Branzi
Management of asymptomatic mitral regurgitation
Heart, December 1, 2010; 96(23): 1938 - 1945.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. H. Adams, R. Rosenhek, and V. Falk
Degenerative mitral valve regurgitation: best practice revolution
Eur. Heart J., August 2, 2010; 31(16): 1958 - 1966.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.